Skip to main content
SpringerLink
Log in

Atypical Antipsychotics in the Treatment of Delusional Parasitosis

  • Case Law Studies
  • Published:
Annals of Clinical Psychiatry

Abstract

Delusional parasitosis is the false belief that one's body is infested with one or many different living organisms. Historically, it has been treated with conventional antipsychotics with only moderate success. The conventional antipsychotic most commonly used has been pimozide. We report a series of five cases of patients with delusional parasitosis. Our patients' demographic characteristics were similar to those in previously published case reports, but instead of being treated with older antipsychotics, they were all treated with atypical antipsychotic agents with favorable results. We will discuss the rationale for this treatment choice, and will review the role of serotonin/dopamine antagonists in the treatment of delusional parasitosis. We will also comment on the possible role of serotonergic antidepressants in the treatment of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Munro A: Monosymptomatic hypochondriacal psychosis. Br J Hosp Med 1980; 24:34-38

    Google Scholar 

  2. Koo JYM, Gambla G: Psychodermatology: Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis; general discussion and case illustrations. Dermatol Clin 1996; 14(3):429-438

    Google Scholar 

  3. Bhatia M, Jagawat T, Choudhary S: Delusional parasitosis: A clinical profile. Int J Psychiatry Med 2000; 30(1):83-91

    Google Scholar 

  4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn., text rev. Washington, DC: American Psychiatric Association; 2000:323-329

    Google Scholar 

  5. Reilly TM, Batchelor DH: The presentation and treatment of delusional parasitosis: A dermatologic perspective. Int Clin Psychopharmacol 1986; 1:340-353

    Google Scholar 

  6. Wykoff RF: Delusions of parasitosis: A review. Rev Infect Dis 1987; 9:433-437

    Google Scholar 

  7. Lell A: The Michelson lecture, delusion of parasitosis. Br J Dermatol 1983; 108:485-499

    Google Scholar 

  8. Trabert W: Shared psychotic disorder in delusional parasitosis. Psychopathology 1999; 32:30-34

    Google Scholar 

  9. Trabert W: 100 years of delusional parasitosis. Psychopathology 1995; 28:238-246

    Google Scholar 

  10. Berrios GE: Delusional parasitosis and physical disease. Compr Psychiatry 1985; 26:395-403

    Google Scholar 

  11. Baker PB, Cook BI, Winokur G: Delusional infestation. Psychiatr Clin North Am 1995; 18:345-361

    Google Scholar 

  12. May WW, Terpenning MS: Delusional parasitosis in geriatric patients. Psychosomatics 1991; 32:88-94

    Google Scholar 

  13. Musalek M, Bach M, Passweg V, Jaeger S: The position of delusional parasitosis in psychiatric nosology and classification. Psychopathology 1990; 23:115-124

    Google Scholar 

  14. Rasanen P, Erkonen K, Isaksson U, Koiio P, Varis R, Timonen M, Leinonen E, Isohanni M, Alanko A: Delusional parasitosis in the elderly: A review and report of six cases from northern Finland. Int Psychogeriatr 1997; 9(4):459-464

    Google Scholar 

  15. Zomer SF, De Wit RF, Van Bonswijik JE, Nabarro G, Van Vloten WA: Delusions of parasitosis: A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol 1998; 138:1030-1032

    Google Scholar 

  16. Richelson E: Receptor pharmacology and neuroleptics: Relation to clinical effects. J Clin Psychiatry 1999; 60:5-14

    Google Scholar 

  17. Elmer KB, Georg RM, Peterson K: Therapeutic update: Use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Am Acad Dermatol 2000; 43:683-686

    Google Scholar 

  18. Riding BE, Munro A: Pimozide in monosymptomatic delusional parasitosis. Lancet 1975; 1:400-401

    Google Scholar 

  19. Monro A, Mok H: An overview of treatment in paranoia/delusional disorder. Can J Psychiatry 1995; 40:616-622

    Google Scholar 

  20. Hanumantha K, Pradhan PV, Suvarna B: Delusional parasitosis—Study of 3 cases. J Postgrad Med 1994; 40:222-224

    Google Scholar 

  21. Johnson GC, Anton RF: Pimozide in delusions of parasitosis. J Clin Psychiatry 1983; 44:233

    Google Scholar 

  22. King BH: Hypothesis: Involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis. Pharmacopsychiatry 1990; 23:85-89

    Google Scholar 

  23. DeLeon OA, Furmaga KM, Canterbury AL, Baily LG: Risper-done in the treatment of delusions of infestation. Int J Psychiatry Med 1997; 27:403-409

    Google Scholar 

  24. Kitamura H: A case of somatic delusional disorder that responded to treatment with risperidone Psychiatry Clin Neurosci 1997; 51(5):337

    Google Scholar 

  25. Songer DA, Roamn B: Treatment of somatic delusional disorder with atypical antipsychotic agents. Am J Psychiatry 1996; 153:578-579

    Google Scholar 

  26. Heym J, Jacobs BL: Serotonergic mechanisms of hallucinogenic drug effects. Monogr Neural Sci 1987; 13:55-81

    Google Scholar 

  27. Driscoll MS, Rothe MJ, Grant-Kels JM, Hale MS: Delusional parasitosis: A dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol 1993; 29:1023-1033

    Google Scholar 

  28. Peroutka SJ, Snyder SH: Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 1980; 137(12):1518-1522

    Google Scholar 

  29. Bymaster FP: In vitro and in vivo biochemistry of olanzapine. J Clin Psychiatry 1997; 15(2):10-12

    Google Scholar 

  30. McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibition-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57:794-801

    Google Scholar 

  31. Stein DJ, Bouwer MB, Hawkridge S, Emsley RA: Risperdone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry 1997; 58:119-122

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine, Tampa, Florida

    Michael T. Wenning, Leigh E. Davy & Glenn Catalano

  2. Psychiatry Service, James A. Haley Veterans' Hospital, Tampa, Florida

    Maria C. Catalano

Authors
  1. Michael T. Wenning
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leigh E. Davy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Glenn Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria C. Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Glenn Catalano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenning, M.T., Davy, L.E., Catalano, G. et al. Atypical Antipsychotics in the Treatment of Delusional Parasitosis. Ann Clin Psychiatry 15, 233–239 (2003). https://doi.org/10.1023/B:ACLI.0000008687.21295.8a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:ACLI.0000008687.21295.8a

Search

Navigation